SoftOx Solutions AS — Regulatory Filings 2021

Jul 2, 2021

SOFTOX SOLUTIONS AS HAS SUBMITTED A NEW APPLICATION FOR NATIONAL APPROVAL FOR ITS DISINFECTION PRODUCTS

SOFTOX SOLUTIONS AS HAS SUBMITTED A NEW APPLICATION FOR NATIONAL APPROVAL FOR ITS DISINFECTION PRODUCTS

With reference to the stock exchange announcement on March 29, 2021, SoftOx has now submitted a new application for national approval of its biocidal products in Norway. The application addresses the objections raised in the first application and only applies to the Norwegian market.

“The company experienced that the previous application involving Norway, Sweden and Denmark entailed great procedural complexity, which we consider to be a contributing factor to the application being rejected. The new improved application now addresses the weaknesses that were commented on in the previous application. New applications to other countries will be submitted on an ongoing basis. In addition, SoftOx has appealed the rejection of the first application.” says CEO Geir Almås.

For further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS, or

Mail: ir@soft-ox.com

Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS

SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth

Oslo. Our vision is “Helping the world fighting infections - developing new ways

of eradicating infections and fighting antimicrobial resistance”. We are working

to combat major threats to human health, namely the emergence of antimicrobial

resistance (AMR), biofilm infections in chronic wounds and the spread of

viruses. For more information on SoftOx, visit www.soft-ox.com.